All stocksTop gainersBiggest losersLarge-capSmall-capLargest employersHigh-dividendHighest net incomeHighest cashHighest profit per employeeHighest revenue per employeeMost activeUnusual volumeMost volatileHigh betaBest performingHighest revenueMost expensivePenny stocksOverboughtOversoldAll-time highAll-time low52-week high52-week lowCreate more lists in Screener
All stocksTop gainersBiggest losersLarge-capSmall-capLargest employersHigh-dividendHighest net incomeHighest cashHighest profit per employeeHighest revenue per employeeMost activeUnusual volumeMost volatileHigh betaBest performingHighest revenueMost expensivePenny stocksOverboughtOversoldAll-time highAll-time low52-week high52-week low
Belgian stocks at their lowest yearly price
Below, Belgian stocks at their 52-week lows are gathered in one list: study their performance and companies' financials to see which ones have potential to grow back.
Symbol | Price | Chg % | Vol | Rel vol | Mkt cap | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 BELYSBelysse Group NV | 0.412 EUR | −1.90% | 23.11 K | 3.15 | 14.81 M EUR | — | −0.35 EUR | −23,200.00% | 0.00% | Consumer durables | Buy |
 EKOPEkopak NV | 3.460 EUR | −2.54% | 12.37 K | 4.46 | 60.56 M EUR | — | −0.48 EUR | +56.40% | 0.00% | Industrial services | No rating |
 HYLHyloris Pharmaceuticals SA | 4.20 EUR | 0.00% | 894 | 0.67 | 117.6 M EUR | — | −0.23 EUR | +0.13% | 0.00% | Health technology | Buy |
 IMMOImmobel SA | 18.55 EUR | −2.62% | 7.04 K | 1.14 | 189.68 M EUR | 6.51 | 2.85 EUR | +8.15% | 0.00% | Finance | Buy |
 INCLUInclusio SA | 16.20 EUR | +0.31% | 5.12 K | 2.47 | 126.48 M EUR | 5.89 | 2.75 EUR | +26.76% | 3.99% | Finance | Neutral |
 MOPPalmboomen Cultuur Maatschappij Mopoli (Palmeraies de Mopoli) NV | 210 EUR | −5.41% | 3 | 0.40 | 34.81 M EUR | 16.15 | 13.00 EUR | −25.23% | 18.89% | Finance | No rating |
 OXUROxurion NV | 0.0018 EUR | −18.18% | 5.38 M | 6.46 | 253.32 K EUR | — | −0.18 EUR | −402.52% | 0.00% | Health technology | No rating |